Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Printing in the Life Sciences, Biofabrication & Synthetic Biology

Paul Gatenholm's Biography



Paul Gatenholm, Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway

Dr. Gatenholm is professor of Biopolymer Technology at Chalmers University of Technology, Founder of 3D Bioprinting Center, and Director of Graduate School at WWSC. He is also Adjunct Professor at Joint School of Biomedical Engineering and Sciences at Virginia Tech and Wake Forest University and Adjunct Professor of Biomaterials at Wake Forest Institute for Regenerative Medicine in Winston-Salem, North Carolina, USA. His research includes biological fabrication through the use of enzymes, cells, and the coordination of biological systems. Dr. Gatenholm is particularly interested in designing and preparing new biomaterials which can replace or regenerate tissue and organs. During past five years he has dedicated his time to development of 3D Bioprinting technology which he believes will revolutionize the field of Medicine. He has published more than 300 papers and edited several books and has more than 9000 citations. He is elected member of Swedish Royal Academy of Engineering Sciences. Dr Gatenholm is an entrepreneur and is currently CEO of new biotech start up in Oslo, Norway.

Paul Gatenholm Image

3D Bioprinting with Stem Cells for Soft Tissue Engineering

Friday, 18 March 2016 at 14:00

Add to Calendar ▼2016-03-17 14:30:002016-03-17 15:30:00Europe/London3D Bioprinting with Stem Cells for Soft Tissue EngineeringSELECTBIOenquiries@selectbiosciences.com

The introduction of 3D-bioprinting is expected to revolutionize the field of tissue engineering and regenerative medicine, which enables the reconstruction of living tissue and organs using the patient’s own cells. We have developed novel bioinks based on polysaccharide nanofibrils with unique combination of printing fidelity good mechanical properties and biocompatibility. Nanofibril dispersion have extremely shear thinning properties and high zero shear viscosity. 3D bioprinting fidelity which is achieved with these bioinks made it possible to print complex cartilage tissue shapes such as ear, nose and meniscus.

3D Bioprinting with Stem Cells for Soft Tissue Engineering

Thursday, 17 March 2016 at 14:30

Add to Calendar ▼2016-03-17 14:30:002016-03-17 15:30:00Europe/London3D Bioprinting with Stem Cells for Soft Tissue EngineeringSELECTBIOenquiries@selectbiosciences.com

The introduction of 3D bioprinting is expected to revolutionize the field of tissue engineering and regenerative medicine, which enables the reconstruction of living tissue and organs using the patient’s own cells. We have developed novel bioinks based on polysaccharide nanofibrils with unique combination of printing fidelity good mechanical properties and biocompatibility. Nanofibril dispersion have extremely shear thinning properties and high zero shear viscosity. 3D bioprinting fidelity which is achieved with these bioinks made it possible to print complex cartilage tissue shapes such as ear, nose and meniscus.


Add to Calendar ▼2016-03-17 00:00:002016-03-18 00:00:00Europe/London3D-Printing in the Life Sciences, Biofabrication and Synthetic BiologySELECTBIOenquiries@selectbiosciences.com